Therefore, in pre-neoplastic nodules, these proteins can activate the production of immune mediators, promoting chronic inflammation and tissue damage, whereas during the malignant phase, extracellular HSPs and calreticulin might dampen effective antitumor immune responses by affecting tumor antigen cross-presentation. Here, CALR is linked to neoplasm.